[1]
Niraula, S. et al. 2013. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. Canadian Urological Association Journal. 7, 1-2 (Feb. 2013), E74–81. DOI:https://doi.org/10.5489/cuaj.267.